Xeris Pharmaceuticals Inc reported $148.92M in Current Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acelrx Pharmaceuticals ACRX:US USD 24.54M 7.46M
Eli Lilly And LLY:US USD 17.64B 524.7M
Endo International Ordinary Shares ENDP:US USD 2.05B 145.74M
Horizon Pharma HZNP:US USD 3.41B 208.92M
JAZZ PHA JAZZ:US USD 2.57B 19.33M
Nektar Therapeutics NKTR:US USD 599.48M 66.05M
Pacira Pharmaceuticals PCRX:US USD 533.41M 7.2M
Perrigo Ordinary Shares PRGO:US USD 2.58B 68.2M
Supernus Pharmaceuticals SUPN:US USD 663.89M 38.77M
Teva Pharmaceutical Industries TEVA:US USD 11.45B 711M